Sign Up to like & get
recommendations!
1
Published in 2022 at "American Journal of Hematology"
DOI: 10.1002/ajh.26583
Abstract: In this open‐label, single‐arm, phase I/II clinical trial, we evaluated the efficacy of anti‐B cell maturation antigen (BCMA) chimeric antigen receptor (CAR)‐T cell (HDS269B) therapy in 49 relapsed/refractory multiple myeloma (RRMM) patients, including 20 with…
read more here.
Keywords:
cell;
therapy;
car;
maturation antigen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "International Journal of Cancer"
DOI: 10.1002/ijc.33002
Abstract: Despite major advances in the treatment of multiple myeloma (MM), it remains a largely incurable disease with long‐term control often dependent on continuous therapy. More effective, better tolerated treatments are therefore required to achieve durable…
read more here.
Keywords:
maturation antigen;
multiple myeloma;
antigen;
cell maturation ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2021 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2021.1872540
Abstract: ABSTRACT Introduction: B-cell maturation antigen (BCMA) targeted therapy (BCMA-TT) has emerged as a promising treatment for Multiple Myeloma (MM). the three most common treatment modalities for targeting BCMA are antibody-drug conjugates (ADCs), bispecific antibody constructs,…
read more here.
Keywords:
maturation antigen;
antibody;
multiple myeloma;
antigen ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2020 at "British Journal of Haematology"
DOI: 10.1111/bjh.16752
Abstract: Serum B‐cell maturation antigen (sBCMA) is a novel biomarker for B‐cell malignancies. A normal reference range (
read more here.
Keywords:
maturation antigen;
serum cell;
treatment;
cell maturation ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2022 at "British Journal of Haematology"
DOI: 10.1111/bjh.18230
Abstract: The delivery of bispecific antibodies (BsAbs) targeting B‐cell maturation antigen (BCMA) and CD3 using the gene therapy approach is a promising alternative for BsAb administration in patients with multiple myeloma (MM). In the present study,…
read more here.
Keywords:
cell maturation;
cd3;
maturation antigen;
gene therapy ... See more keywords
Sign Up to like & get
recommendations!
0
Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-131849
Abstract: Introduction Multiple Myeloma (MM) is a plasma cell dyscrasia characterized by neoplastic proliferation of plasma cells. Despite the recent advances in disease management, it still contributes to significant morbidity and mortality, thus highlighting the unmet…
read more here.
Keywords:
maturation antigen;
myeloma;
bcma;
multiple myeloma ... See more keywords
Sign Up to like & get
recommendations!
1
Published in 2018 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2018.01821
Abstract: The approval of the first two monoclonal antibodies targeting CD38 (daratumumab) and SLAMF7 (elotuzumab) in late 2015 for treating relapsed and refractory multiple myeloma (RRMM) was a critical advance for immunotherapies for multiple myeloma (MM).…
read more here.
Keywords:
maturation antigen;
bcma;
multiple myeloma;
antigen ... See more keywords